
A delegation of Ohio State Senators visited P-Cure headquarters in Israel to explore the advances being made in proton therapy.
P-Cure (P-Cure, Ltd.), a leading provider of Patient-Centric solutions for proton therapy, has received U.S. Food and Drug...
Read MoreWarrenville, Ill., (Dec. 16) – P-Cure, Ltd has received a 510(k) letter from the U.S. Food and Drug Administration (FDA) permitting it...
Read MoreP-Cure brings a paradigm-changing solution to cancer care for proton patients. Our mission is to provide comprehensive clinical solution for precise planning and delivery, to expand proton therapy access through significantly more affordable proton facilities, and to be committed to compassionate care for patients being treated for cancer. P-Cure puts the patient first. If you’re considering offering proton therapy to patients,